10-KPeriod: FY2019

ENTEGRIS INC Annual Report, Year Ended Dec 31, 2019

Filed February 7, 2020For Securities:ENTG

Summary

Entegris Inc. (ENTG) is a leading global supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. For the fiscal year ended December 31, 2019, the company reported net sales of $1.59 billion, a slight increase of 3% compared to the previous year, driven largely by recent acquisitions. Despite overall sales growth, the company experienced a decrease in gross profit and margins due to lower factory utilization and an unfavorable sales mix. Entegris operates across three key segments: Specialty Chemicals and Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment saw a slight decrease in sales, while MC experienced robust growth, and AMH saw a decline. The company continues to invest heavily in R&D to maintain its technological leadership, crucial for developing mission-critical solutions that maximize customer yields and enhance device performance in an increasingly complex semiconductor manufacturing landscape. Strategic acquisitions in 2019, including DSC, MPD Chemicals, and Anow, bolster its engineered materials and filtration capabilities.

Financial Statements
Beta

Key Highlights

  • 1Net sales reached $1.59 billion for the fiscal year ended December 31, 2019, representing a 3% increase year-over-year, primarily driven by acquisitions.
  • 2The company operates through three distinct segments: Specialty Chemicals and Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH), each serving critical aspects of semiconductor manufacturing.
  • 3Investment in Engineering, Research & Development (ER&D) remained strong at $121.1 million, representing 7.6% of net sales, underscoring a commitment to innovation and maintaining technological leadership.
  • 4Entegris made strategic acquisitions in 2019, including Digital Specialty Chemicals Limited (DSC), MPD Chemicals, and Hangzhou Anow Microfiltration Co., Ltd. (Anow), to expand its product offerings and market reach.
  • 5The Microcontamination Control (MC) segment demonstrated significant growth with a 14% increase in net sales, highlighting the importance of its purification and filtration solutions.
  • 6The company's financial performance is heavily influenced by the cyclical nature of the semiconductor industry, with sales heavily dependent on customer demand and capital spending.
  • 7Significant revenue is derived from key customers, with the top ten customers accounting for 43% of net sales in 2019, indicating a concentration risk.

Frequently Asked Questions

Entegris operates in three segments: Specialty Chemicals and Engineered Materials (SCEM) provides high-performance process chemistries, gases, and materials. Microcontamination Control (MC) offers solutions to filter and purify critical liquid chemistries and gases. Advanced Materials Handling (AMH) develops solutions to monitor, protect, transport, and deliver critical liquid chemistries and wafers.

Entegris sees strong growth potential driven by emerging applications like 5G, IoT, AI, and autonomous vehicles, which require more powerful and complex semiconductors. The trend towards smaller and more intricate manufacturing processes, requiring higher material intensity and purity, positions Entegris favorably to meet customer demands.

Key risks include the cyclicality of the semiconductor industry, intense competition, reliance on a few key customers, potential supply chain disruptions, and the need for continuous innovation to keep pace with rapid technological changes. Global economic conditions and trade policies also pose risks.

Entegris focuses on technology leadership, operational excellence, and customer intimacy. The company has actively pursued strategic acquisitions to fill product gaps, diversify into complementary markets, and broaden its technological capabilities. Notable 2019 acquisitions include DSC, MPD Chemicals, and Anow.